|
|
|
201-500 employees
View all
|
|
pharmaceuticals
|
|
950 Winter Street,Waltham,MA,US
|
|
We are a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics. Radius' lead product, TYMLOS® (abaloparatide) injection was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in osteoporosis; and the investigational drug elacestrant (RAD1901) for potential use in hormone-receptor positive breast cancer out-licensed to Menarini Group. Radius was founded in 2003 and has locations in Waltham, Massachusetts, and Wayne, Pennsylvania. If you think you have the same passion and commitment we have, check out www.radiuspharm.com.
|
Radius Health, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
83.33%
|
The widely used Radius Health, Inc. email format is {f}{last} (e.g. [email protected]) with 83.33% adoption across the company.
To contact Radius Health, Inc. customer service number in your country click here to find.
Jesper Høiland is the CEO of Radius Health, Inc.. To contact Jesper Høiland email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.